BBIO
BridgeBio Pharma Inc
NASDAQ: BBIO · HEALTHCARE · BIOTECHNOLOGY
$70.94
+1.76% today
Updated 2026-04-29
Market cap
$13.75B
P/E ratio
—
P/S ratio
27.39x
EPS (TTM)
$-3.78
Dividend yield
—
52W range
$32 – $85
Volume
2.5M
BridgeBio Pharma Inc (BBIO) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-40.49M | $-136.64M | $-253.59M | $-399.71M | $-497.93M | $-419.49M | $-527.72M | $-520.73M | $-445.91M |
| Capital expenditures | $464000.00 | $18.18M | $5.14M | $7.52M | $48.25M | $6.32M | $1.31M | $933000.00 | $1.10M |
| Depreciation | $260000.00 | $245000.00 | $3.09M | $3.09M | $5.84M | $6.77M | $6.49M | $6.08M | — |
| Stock-based comp | $1.84M | $6.07M | $21.37M | $58.46M | $99.50M | $91.56M | $115.02M | $95.80M | $133.02M |
| Free cash flow | $-40.95M | $-154.82M | $-258.73M | $-407.23M | $-546.18M | $-425.81M | $-529.03M | $-521.66M | $-447.01M |
| Investing cash flow | $-464000.00 | $-21.04M | $-217.25M | $-52.99M | $-200.83M | $453.15M | $54.03M | $60.78M | — |
| Financing cash flow | $112.98M | $501.55M | $398.79M | $447.19M | $736.45M | $-13.13M | $451.54M | $748.46M | — |
| Dividends paid | $1.15M | $0.00 | $997000.00 | $536.96M | $3.82M | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $-5.52M | $37.69M | $20.52M | — | — | — |